Parallax Volatility Advisers, L.P. Seelos Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $8,450 - $14,450	5,000 New	5,000 $12,000
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $134,017 - $229,177	-79,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $209,352 - $501,176	79,300 New	79,300 $209,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.